{"id":"F2006L03689","name":"National Health Act 1953 - Determination under paragraph 98C(1)(b) (No. PB 50 of 2006)","slug":"national-health-act-1953-determination-under-paragraph-98c-1-b-no-pb-50-of-2006","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":137450,"registerId":"commonwealth-F2006L03689-current","compilationNumber":null,"startDate":"2026-04-03","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health Act 1953 - Determination under paragraph 98C(1)(b) (No. PB 50 of 2006)","content":"![](image.001.png)\n\nDetermination under paragraph 98C (1) (b) (No. PB 50 of 2006)\n\nas amended\n\nmade under the\n\nNational Health Act 1953\n\nThis compilation was prepared on 1 February 2007 \ntaking into account amendments up to No. PB 9 of 2007\n\nPrepared by the Office of Legislative Drafting and Publishing, \nAttorney-General’s Department, Canberra\n\nPharmaceutical Benefits\n\nDetermination under paragraph 98C (1) (b)\n\nNo. PB 50 of 2006 \\[see Note 1\\]\n\n1. This Determination commences on 1 December 2006.\n\n2. Determination No. PB 32 of 2006 under paragraph 98C(1)(b) of the National Health Act 1953, made on 26 July 2006 with effect from 1 August 2006, is repealed.\n\n3. In this Determination:\n\n“Act” means the National Health Act 1953;\n\n“approved price to pharmacists” has the same meaning as in subsection 98B(3) of the Act;\n\n“Commonwealth price” has the same meaning as in subsection 84(1) of the Act;\n\n“extemporaneously-prepared pharmaceutical benefit” means a pharmaceutical benefit other than a ready-prepared pharmaceutical benefit;\n\n“prescription” includes a prescription written on an authority prescription pursuant to regulation 13 of the Regulations, subparagraph 14(d) of the declaration made under subsection 85(2) of the Act or subparagraph 11(d) of the determinations made under sections 85, 85A and 88 of the Act, a repeat authorisation or a deferred supply authorisation;\n\n“ready-prepared pharmaceutical benefit” means a drug or medicinal preparation in respect of which there is in force a determination under subsection 85(6) of the Act;\n\n“Regulations” means the National Health (Pharmaceutical Benefits) Regulations 1960 made under the Act;\n\n“standard formula preparation” means an extemporaneously-prepared pharmaceutical benefit that is listed in Schedule 5 to this Determination.\n\n4. For the purpose of the determination made under subsection 98B(1) of the Act:\n\n(a) pharmaceutical benefits that involve the admixture of ready-prepared ingredients are set out in Schedule 1 to this Determination;\n\n(b) drugs that are used in the preparation of extemporaneously-prepared pharmaceutical benefits and that are unstable or packed sterile and unused quantities of which are unsuitable for future use are set out in Schedule 2 to this Determination;\n\n(c) pharmaceutical benefits that are classified as dangerous drugs for the purpose of payment of a dangerous drug fee are set out in Schedule 3 to this Determination;\n\n(d) pharmaceutical benefits the complete pack of which shall be supplied regardless of any lesser quantity ordered are set out in Schedule 4 to this Determination.\n\n5. Where a prescription identifies the ready-prepared pharmaceutical benefit to be supplied by reference to a particular brand, the amount payable shall be based on the approved price to pharmacists for that brand.\n\n6. Where a prescription does not identify the ready-prepared pharmaceutical benefit to be supplied by reference to a particular brand, the amount payable shall be based on the approved price to pharmacists of the brand of that benefit, being a brand which is available from a wholesale source in the capital city of the State in which the benefit is supplied, for which the Commonwealth price for the supply of the benefit is lowest.\n\n7. Where a prescription calls for a quantity of one of the pharmaceutical benefits listed in Schedule 4 to this Determination that is less than the quantity contained in the size of unit included in the particulars specified in the column headed ‘Form’ in that Schedule in relation to that benefit, the complete pack shall be supplied.\n\n8. A medicinal preparation that is a variation of a standard formula preparation, due to the addition or deletion of an ingredient or to variation of the dose, or that is a combination of standard formula preparations, shall be deemed not to be a standard formula preparation.\n\n9. An election made pursuant to paragraph 38 of the determination made under subsection 98B(1) of the Act shall be made in writing to the Chief Executive Officer of Medicare Australia and shall remain in force for a period of not less than 3 months from and including the date of election, but may be revoked in writing at any time after the expiration of that period; and while the election remains in force, the amount payable to the approved pharmacist or approved medical practitioner, in respect of the supply of an extemporaneously-prepared pharmaceutical benefit that is not a standard formula preparation, shall be the amount calculated in accordance with paragraph 21 of the determination made under subsection 98B(1) of the Act.\n\n```html\n

Amoxycillin Trihydrate with Potassium Clavulanate and Water - Purified BP

Powder for oral suspension equivalent to 125 mg amoxycillin-31.25 mg clavulanic acid per 5 mL, 75 mL

Powder for oral suspension equivalent to 400 mg amoxycillin-57 mg clavulanic acid per 5 mL, 60 mL

Amoxycillin Trihydrate with Water - Purified BP

Powder for paediatric oral drops equivalent to 100 mg amoxycillin per mL, 20 mL

Powder for oral suspension equivalent to 125 mg amoxycillin per 5 mL, 100 mL

Powder for oral suspension equivalent to 250 mg amoxycillin per 5 mL, 100 mL

Powder for oral suspension equivalent to 500 mg amoxycillin per 5 mL, 100 mL

Azithromycin Dihydrate with Water - Purified BP

Powder for oral suspension equivalent to 200 mg azithromycin per 5 mL, 15 mL

Cefaclor Monohydrate with Water -
Purified BP

Powder for oral suspension equivalent to 125 mg cefaclor per 5 mL, 100 mL

Powder for oral suspension equivalent to 250 mg cefaclor per 5 mL, 75 mL

Cephalexin with Water - Purified BP

Granules for oral suspension 125 mg per 5 mL, 100 mL

Granules for oral suspension 250 mg per 5 mL, 100 mL

Erythromycin Ethyl Succinate with Water - Purified BP

Powder for oral liquid equivalent to 200 mg erythromycin per 5 mL, 100 mL

Powder for oral liquid equivalent to 400 mg erythromycin per 5 mL, 100 mL

Flucloxacillin Magnesium with Water - Purified BP

Powder for oral suspension equivalent to 125 mg flucloxacillin per 5 mL, 100 mL

Powder for oral suspension equivalent to 250 mg flucloxacillin per 5 mL, 100 mL

Mycophenolate Mofetil with Water -
Purified BP

Powder for oral suspension 1 g per 5 mL, 165 mL

\n```\n\nSCHEDULE 2 — LIST OF DRUGS THAT ARE USED IN THE PREPARATION OF EXTEMPORANEOUSLY-PREPARED PHARMACEUTICAL BENEFITS AND THAT ARE UNSTABLE OR PACKED STERILE AND UNUSED QUANTITIES OF WHICH ARE UNSUITABLE FOR FUTURE USE\n\nWater for Injections - sterilised BP\n\n| |\n| --- |\n\n```html\n

Buprenorphine

Transdermal patch 5 mg

Transdermal patch 10 mg

Transdermal patch 20 mg

Codeine Phosphate

Tablet 30 mg

Dexamphetamine Sulfate

Tablet 5 mg

Fentanyl

Transdermal patch 2.1 mg

Transdermal patch 4.2 mg

Transdermal patch 8.4 mg

Transdermal patch 12.6 mg

Transdermal patch 16.8 mg

Hydromorphone Hydrochloride

Tablet 2 mg

Tablet 4 mg

Tablet 8 mg

Oral liquid 1 mg per mL, 473 mL

Injection 2 mg in 1 mL ampoule

Injection 10 mg in 1 mL ampoule

Injection 50 mg in 5 mL ampoule

Injection 500 mg in 50 mL vial

Methadone Hydrochloride

Tablet 10 mg

Oral liquid 25 mg per 5 mL, 200 mL

Injection 10 mg in 1 mL ampoule

Methylphenidate Hydrochloride

Tablet 10 mg

Morphine Hydrochloride

Oral solution 2 mg per mL, 200 mL

Oral solution 5 mg per mL, 200 mL

Oral solution 10 mg per mL, 200 mL

Morphine Sulfate

Tablet 10 mg

Tablet 20 mg

Tablet 30 mg

Tablet 5 mg (controlled release)

Tablet 10 mg (controlled release)

Tablet 15 mg (controlled release)

Tablet 30 mg (controlled release)

Tablet 60 mg (controlled release)

Tablet 100 mg (controlled release)

Tablet 200 mg (controlled release)

Capsule 10 mg (containing sustained release pellets)

Capsule 20 mg (containing sustained release pellets)

Capsule 30 mg (controlled release)

Capsule 50 mg (containing sustained release pellets)

Capsule 60 mg (controlled release)

Capsule 90 mg (controlled release)

Capsule 100 mg (containing sustained release pellets)

Capsule 120 mg (controlled release)

Sachet containing controlled release granules for oral suspension, 20 mg per sachet

Sachet containing controlled release granules for oral suspension, 30 mg per sachet

Sachet containing controlled release granules for oral suspension, 60 mg per sachet

Sachet containing controlled release granules for oral suspension, 100 mg per sachet

Sachet containing controlled release granules for oral suspension, 200 mg per sachet

Injection 10 mg in 1 mL ampoule

Injection 15 mg in 1 mL ampoule

Injection 30 mg in 1 mL ampoule

Morphine Tartrate

Injection 120 mg in 1.5 mL ampoule

Oxycodone Hydrochloride

Tablet 5 mg

Capsule 5 mg

Capsule 10 mg

Capsule 20 mg

Oral solution 5 mg per 5 mL, 250 mL

Tablet 5 mg (controlled release)

Tablet 10 mg (controlled release)

Tablet 20 mg (controlled release)

Tablet 40 mg (controlled release)

Tablet 80 mg (controlled release)

Oxycodone Pectinate

Suppository equivalent to 30 mg oxycodone

Pethidine Hydrochloride

Injection 100 mg in 2 mL ampoule

\n```\n\n```html\n

Aciclovir

Eye ointment 30 mg per g, 4.5 g

Amoxycillin Trihydrate with Potassium Clavulanate and Water - Purified BP

Powder for oral suspension equivalent to 125 mg amoxycillin-31.25 mg clavulanic acid per 5 mL, 75 mL

Powder for oral suspension equivalent to 400 mg amoxycillin-57 mg clavulanic acid per 5 mL, 60 mL

Amoxycillin Trihydrate with Water - Purified BP

Powder for paediatric oral drops equivalent to 100 mg amoxycillin per mL, 20 mL

Powder for oral suspension equivalent to 125 mg amoxycillin per 5 mL, 100 mL

Powder for oral suspension equivalent to 250 mg amoxycillin per 5 mL, 100 mL

Powder for oral suspension equivalent to 500 mg amoxycillin per 5 mL, 100 mL

Apraclonidine Hydrochloride

Eye drops equivalent to 5 mg apraclonidine per mL, 10 mL

Aprepitant

Pack containing 1 capsule 125 mg and 2 capsules 80 mg

Atovaquone

Oral suspension 750 mg per 5 mL, 210 mL

Atropine Sulfate

Eye drops 10 mg per mL, 15 mL

Azithromycin Dihydrate with Water - Purified BP

Powder for oral suspension equivalent to 200 mg azithromycin per 5 mL, 15 mL

Beclomethasone Dipropionate

Pressurised inhalation 50 micrograms per dose, 200 doses (CFC-free formulation)

Pressurised inhalation 100 micrograms per dose, 200 doses (CFC-free formulation)

Pressurised inhalation in breath actuated device 50 micrograms per dose, 200 doses (CFC-free formulation)

Pressurised inhalation in breath actuated device 100 micrograms per dose, 200 doses (CFC-free formulation)

Benzydamine Hydrochloride

Mouth and throat rinse 22.5 mg per 15 mL, 500 mL

Betamethasone Dipropionate

Cream equivalent to 500 micrograms betamethasone per g, 15 g

Ointment equivalent to 500 micrograms betamethasone per g, 15 g

Betamethasone Valerate

Cream equivalent to 500 micrograms betamethasone per g, 15 g

Ointment equivalent to 500 micrograms betamethasone per g, 15 g

Betaxolol Hydrochloride

Eye drops, suspension, equivalent to 2.5 mg betaxolol per mL, 5 mL

Eye drops, solution, equivalent to 5 mg betaxolol per mL, 5 mL

Bimatoprost

Eye drops 300 micrograms per mL, 3 mL

Bisacodyl

Enemas 10 mg in 5 mL, 25

Brimonidine Tartrate

Eye drops 2 mg per mL, 5 mL

Brimonidine Tartrate with Timolol Maleate

Eye drops 2 mg brimonidine tartrate with timolol maleate equivalent to 5 mg timolol per mL, 5 mL

Brinzolamide

Eye drops 10 mg per mL, 5 mL

Budesonide

Nebuliser suspension 500 micrograms in 2 mL single dose units, 30

Nebuliser suspension 1 mg in 2 mL single dose units, 30

Powder for oral inhalation in breath actuated device 100 micrograms per dose, 200 doses

Powder for oral inhalation in breath actuated device 200 micrograms per dose, 200 doses

Powder for oral inhalation in breath actuated device 400 micrograms per dose, 200 doses

Budesonide with Eformoterol Fumarate Dihydrate

Powder for oral inhalation in breath actuated device 100 micrograms-6 micrograms per dose, 120 doses

Powder for oral inhalation in breath actuated device 200 micrograms-6 micrograms per dose, 120 doses

Calcipotriol

Ointment 50 micrograms per g, 30 g

Captopril

Oral solution 5 mg per mL, 95 mL

Carbamazepine

Oral suspension 100 mg per 5 mL, 300 mL

Carbomer 980

Ocular lubricating gel 2 mg per g, 10 g

Carmellose Sodium

Eye drops 5 mg per mL, 15 mL

Eye drops 10 mg per mL, 15 mL

Mouth spray 10 mg per mL, 25 mL

Mouth spray 10 mg per mL, 100 mL

Carmustine

Implants 7.7 mg, 8

Cefaclor Monohydrate with Water -
Purified BP

Powder for oral suspension equivalent to 125 mg cefaclor per 5 mL, 100 mL

Powder for oral suspension equivalent to 250 mg cefaclor per 5 mL, 75 mL

Cephalexin with Water - Purified BP

Granules for oral suspension 125 mg per 5 mL, 100 mL

Granules for oral suspension 250 mg per 5 mL, 100 mL

Chloramphenicol

Ear drops (aqueous) 5 mg per mL, 5 mL

Eye drops 5 mg per mL, 10 mL

Eye ointment 10 mg per g, 4 g

Chlorpromazine Hydrochloride

Oral solution 25 mg per 5 mL, 100 mL

Cholestyramine

Sachets containing 9.4 g oral powder (equivalent to 8 g cholestyramine), 50

Ciclesonide

Pressurised inhalation 80 micrograms per dose, 120 doses (CFC-free formulation)

Pressurised inhalation 160 micrograms per dose, 120 doses (CFC-free formulation)

Ciprofloxacin Hydrochloride

Ear drops equivalent to 3 mg ciprofloxacin per mL, 5 mL

Coal Tar - Prepared

Gel 10 mg per g, 100 mL

Colestipol Hydrochloride

Oral powder, sachets 5 g, 120

Desmopressin Acetate

Nasal spray (pump pack) 10 micrograms per actuation, 60 actuations, 6 mL

Dexamethasone

Eye drops 1 mg per mL, 5 mL

Dexamethasone Sodium Metasulfobenzoate with Framycetin Sulfate and Gramicidin

Ear drops 500 micrograms (dexamethasone)-5 mg-50 micrograms per mL, 8 mL

Dipivefrine Hydrochloride

Eye drops 1 mg per mL, 10 mL

Disodium Etidronate and Calcium Carbonate

Pack containing 28 tablets disodium etidronate 200 mg and 76 tablets calcium carbonate 1.25 g (equivalent to 500 mg calcium)

Dorzolamide Hydrochloride

Eye drops equivalent to 20 mg dorzolamide per mL, 5 mL

Dorzolamide Hydrochloride with Timolol Maleate

Eye drops equivalent to 20 mg dorzolamide-5 mg timolol per mL, 5 mL

Eformoterol Fumarate Dihydrate

Powder for oral inhalation in breath actuated device 6 micrograms per dose, 60 doses

Powder for oral inhalation in breath actuated device 12 micrograms per dose, 60 doses

Erythromycin Ethyl Succinate with Water - Purified BP

Powder for oral liquid equivalent to 200 mg erythromycin per 5 mL, 100 mL

Powder for oral liquid equivalent to 400 mg erythromycin per 5 mL, 100 mL

Escitalopram Oxalate

Oral solution equivalent to 10 mg escitalopram per mL, 28 mL

Esomeprazole Magnesium Trihydrate and Clarithromycin and Amoxycillin Trihydrate

Pack containing 14 tablets (enteric coated) esomeprazole magnesium trihydrate equivalent to 20 mg esomeprazole, 14 tablets clarithromycin 500 mg and 28 capsules amoxycillin trihydrate equivalent to 500 mg amoxycillin

Ethosuximide

Oral solution 250 mg per 5 mL, 200 mL

Ferrous Sulfate

Oral liquid 30 mg per mL, 250 mL

Flucloxacillin Magnesium with Water - Purified BP

Powder for oral suspension equivalent to 125 mg flucloxacillin per 5 mL, 100 mL

Powder for oral suspension equivalent to 250 mg flucloxacillin per 5 mL, 100 mL

Fluorometholone

Eye drops 1 mg per mL, 5 mL

Fluorometholone Acetate

Eye drops 1 mg per mL, 5 mL

Fluticasone Propionate

Pressurised inhalation 50 micrograms per dose, 120 doses (CFC-free formulation)

Pressurised inhalation 125 micrograms per dose, 120 doses (CFC-free formulation)

Pressurised inhalation 250 micrograms per dose, 120 doses (CFC-free formulation)

Powder for oral inhalation in breath actuated device 100 micrograms per dose, 60 doses

Powder for oral inhalation in breath actuated device 250 micrograms per dose, 60 doses

Powder for oral inhalation in breath actuated device 500 micrograms per dose, 60 doses

Fluticasone Propionate with Salmeterol Xinafoate

Pressurised inhalation 50 micrograms fluticasone propionate with salmeterol xinafoate equivalent to 25 micrograms salmeterol per dose, 120 doses (CFC-free formulation)

Pressurised inhalation 125 micrograms fluticasone propionate with salmeterol xinafoate equivalent to 25 micrograms salmeterol per dose, 120 doses (CFC-free formulation)

Pressurised inhalation 250 micrograms fluticasone propionate with salmeterol xinafoate equivalent to 25 micrograms salmeterol per dose, 120 doses (CFC-free formulation)

Powder for oral inhalation in breath actuated device 100 micrograms fluticasone propionate with salmeterol xinafoate equivalent to 50 micrograms salmeterol per dose, 60 doses

Powder for oral inhalation in breath actuated device 250 micrograms fluticasone propionate with salmeterol xinafoate equivalent to 50 micrograms salmeterol per dose, 60 doses

Powder for oral inhalation in breath actuated device 500 micrograms fluticasone propionate with salmeterol xinafoate equivalent to 50 micrograms salmeterol per dose, 60 doses

Framycetin Sulfate

Eye or ear drops 5 mg per mL, 8 mL

Frusemide

Oral solution 10 mg per mL, 30 mL

Gentamicin Sulfate

Eye drops equivalent to 3 mg gentamicin per mL, 5 mL

Glucose with Sodium Chloride, Potassium Chloride and Sodium Acid Citrate

Oral rehydration salts 3.56 g-470 mg-300 mg-530 mg per sachet, 10

Glucose Indicator—Blood

Electrode strips, 100 (Optium glucose)

Electrode strips, 100 (Precision Plus)

Electrode strips, 100 (SofTact)

Electrode strips, 100 (TrueSense)

Glyceryl Trinitrate

Tablets 600 micrograms, 100

Buccal/sublingual spray (pump pack) 400 micrograms per dose, 200 doses

Haloperidol

Oral solution 2 mg per mL, 100 mL

Homatropine Hydrobromide

Eye drops 20 mg per mL, 15 mL

Hydrocortisone

Cream 10 mg per g, 50 g

Hydrocortisone Acetate

Eye ointment 5 mg per g, 5 g

Eye ointment 10 mg per g, 5 g

Cream 10 mg per g, 30 g

Cream 10 mg per g, 50 g

Ointment 10 mg per g, 30 g

Ointment 10 mg per g, 50 g

Hypromellose

Eye drops 3 mg per mL, 15 mL

Eye drops 5 mg per mL, 15 mL

Hypromellose with Carbomer 980

Ocular lubricating gel 3 mg-2 mg per g, 10 g

Hypromellose 4500 with Dextran 70

Eye drops 3 mg-1 mg per mL, 15 mL

Ketoconazole

Cream 20 mg per g, 30 g

Shampoo 10 mg per g, 100 mL

Shampoo 20 mg per g, 60 mL

Lactulose

Solution BP 3.34 g per 5 mL, 500 mL

Latanoprost

Eye drops 50 micrograms per mL, 2.5 mL

Latanoprost with Timolol Maleate

Eye drops 50 micrograms latanoprost with timolol maleate equivalent to 5 mg timolol per mL, 2.5 mL

Leflunomide

Pack containing 3 tablets leflunomide 100 mg and 30 tablets leflunomide 20 mg

Levobunolol Hydrochloride

Eye drops 2.5 mg per mL, 5 mL

Macrogol 3350 with Sodium Chloride, Sodium Bicarbonate and Potassium Chloride

Sachets containing powder for oral solution 13.125 g-350.7 mg-178.5 mg-46.6 mg, 30

Mesalazine

Suppositories 1 g, 28

\"Metabolic Mineral Mixture\"

Oral powder 250 g

Methylprednisolone Aceponate

Cream 1 mg per g, 15 g

Ointment 1 mg per g, 15 g

Fatty ointment 1 mg per g, 15 g

Lotion 1 mg per g, 20 g

Metoclopramide Hydrochloride

Oral solution 5 mg per 5 mL, 100 mL

Metoprolol Succinate

Pack containing 15 tablets 23.75 mg (controlled release), 15 tablets 47.5 mg (controlled release) and 15 tablets 95 mg (controlled release)

Metronidazole

Suppositories 500 mg, 10

Metronidazole Benzoate

Oral suspension 320 mg per 5 mL, 100 mL

Miconazole

Tincture 20 mg per mL, 30 mL

Miconazole Nitrate

Cream 20 mg per g, 30 g

Cream 20 mg per g, 70 g

Powder 20 mg per g, 30 g

Lotion 20 mg per mL, 30 g

Mometasone Furoate

Cream 1 mg per g, 15 g

Ointment 1 mg per g, 15 g

Lotion 1 mg per g, 30 mL

Mycophenolate Mofetil with Water -
Purified BP

Powder for oral suspension 1 g per 5 mL, 165 mL

Nafarelin Acetate

Nasal spray (pump pack) equivalent to 200 micrograms nafarelin per dose, 60 doses

Naproxen

Oral suspension 125 mg per 5 mL, 474 mL

Nedocromil Sodium

Pressurised inhalation 2 mg per dose, 112 doses (CFC-free formulation)

Neomycin Undecenoate with Bacitracin Zinc

Ear ointment 12 mg (3.5 mg neomycin)-400 units per g, 10 g

Nicorandil

Tablets 10 mg, 60

Tablets 20 mg, 60

Nystatin

Oral suspension 100,000 units per mL, 24 mL

Oestradiol

Transdermal patches 390 micrograms, 8

Transdermal patches 2 mg, 4

Transdermal patches 2 mg, 8

Transdermal patches 585 micrograms, 8

Transdermal patches 3.28 mg, 8

Transdermal patches 3.8 mg, 4

Transdermal patches 4 mg, 8

Transdermal patches 780 micrograms, 8

Transdermal patches 4.33 mg, 8

Transdermal patches 5.7 mg, 4

Transdermal patches 1.17 mg, 8

Transdermal patches 6.57 mg, 8

Transdermal patches 7.6 mg, 4

Transdermal patches 8 mg, 8

Transdermal patches 1.56 mg, 8

Transdermal patches 8.66 mg, 8

Vaginal tablets 25 micrograms, 15

Oestradiol and Oestradiol with Dydrogesterone

Pack containing 14 tablets oestradiol 2 mg and 14 tablets oestradiol 2 mg with dydrogesterone 10 mg

Oestradiol and Oestradiol with Norethisterone Acetate

Pack containing 12 tablets oestradiol 2 mg, 10 tablets oestradiol 2 mg with norethisterone acetate 1 mg and 6 tablets oestradiol 1 mg

Pack containing 4 transdermal patches oestradiol 4 mg and 4 transdermal patches oestradiol 10 mg with norethisterone acetate 30 mg

Oestradiol Hemihydrate

Nasal spray 150 micrograms per actuation, 60 actuations, 4.2 mL

Transdermal gel equivalent to 1 mg oestradiol in 1 g sachet, 28

Transdermal patches equivalent to 750 micrograms oestradiol, 8

Transdermal patches equivalent to 1.5 mg oestradiol, 8

Transdermal patches equivalent to 3 mg oestradiol, 8

Oestradiol Hemihydrate and Oestradiol Hemihydrate with Norethisterone Acetate

Pack containing 4 transdermal patches equivalent to 4.33 mg oestradiol and 4 transdermal patches equivalent to 620 micrograms oestradiol with 2.7 mg norethisterone acetate

Pack containing 4 transdermal patches equivalent to 4.33 mg oestradiol and 4 transdermal patches equivalent to 510 micrograms oestradiol with 4.8 mg norethisterone acetate

Oestradiol Hemihydrate with Norethisterone Acetate

Tablets equivalent to 1 mg oestradiol with 500 micrograms norethisterone acetate, 28

Tablets equivalent to 2 mg oestradiol with 1 mg norethisterone acetate, 28

Transdermal patches equivalent to 620 micrograms oestradiol with 2.7 mg norethisterone acetate, 8

Transdermal patches equivalent to 510 micrograms oestradiol with 4.8 mg norethisterone acetate, 8

Oestriol

Pessaries 500 micrograms, 15

Vaginal cream 1 mg per g, 15 g

Oestrogens—Conjugated with Medroxyprogesterone Acetate

Tablets 625 micrograms-2.5 mg, 28

Tablets 625 micrograms-5 mg, 28

Omeprazole and Clarithromycin and Amoxycillin Trihydrate

Pack containing 14 capsules omeprazole 20 mg, 14 tablets clarithromycin 500 mg and 28 capsules amoxycillin trihydrate equivalent to 500 mg amoxycillin

Ondansetron Hydrochloride Dihydrate

Syrup equivalent to 4 mg ondansetron per 5 mL, 50 mL

Paracetamol

Oral liquid 120 mg per 5 mL, 100 mL

Oral liquid 240 mg per 5 mL, 200 mL

Suppositories 500 mg, 24

Paraffin - Soft White with Paraffin - Liquid

Pack containing 2 tubes eye ointment, compound, 3.5 g

Permethrin

Cream 50 mg per g, 30 g

Phenytoin

Oral suspension 30 mg per 5 mL, 500 mL

Pilocarpine Hydrochloride

Eye drops 5 mg per mL, 15 mL

Eye drops 10 mg per mL, 15 mL

Eye drops 20 mg per mL, 15 mL

Eye drops 40 mg per mL, 15 mL

Eye drops 60 mg per mL, 15 mL

Pimecrolimus

Cream 10 mg per g, 15 g

Polyethylene Glycol 400 with Propylene Glycol

Eye drops 4 mg-3 mg per mL, 15 mL

Polyvinyl Alcohol

Eye drops 14 mg per mL, 15 mL

Eye drops 14 mg per mL, 15 mL (contains sodium chlorite/hydrogen peroxide as preservative)

Eye drops 30 mg per mL, 15 mL

Eye drops 30 mg per mL, 15 mL (contains sodium chlorite/hydrogen peroxide as preservative)

Prednisolone Acetate with Phenylephrine Hydrochloride

Eye drops 10 mg-1.2 mg per mL, 10 mL

Prednisolone Sodium Phosphate

Oral solution equivalent to 5 mg prednisolone per mL, 30 mL

Prochlorperazine

Suppositories 3 mg, equivalent to 5 mg prochlorperazine maleate, 5

Suppositories 15 mg, equivalent to 25 mg prochlorperazine maleate, 5

Promethazine Hydrochloride

Oral liquid 5 mg per 5 mL, 100 mL

Quinagolide Hydrochloride

Pack containing 3 tablets equivalent to 25 micrograms quinagolide and 3 tablets equivalent to 50 micrograms quinagolide

Ramipril

Pack containing 7 tablets 2.5 mg, 21 tablets 5 mg and 10 capsules 10 mg

Reteplase

Pack containing 2 vials powder for injection 10 units, 2 single use pre-filled syringes with solvent, 2 reconstitution spikes and 2 needles

Rifampicin

Syrup 100 mg per 5 mL, 60 mL

Risedronate Sodium and Calcium Carbonate

Pack containing 4 tablets risedronate sodium 35 mg and 24 tablets calcium carbonate 1.25 g (equivalent to 500 mg calcium)

Risperidone

Oral solution 1 mg per mL, 30 mL

Oral solution 1 mg per mL, 100 mL

Rivastigmine Hydrogen Tartrate

Oral solution equivalent to 2 mg rivastigmine per mL, 120 mL

Salbutamol Sulfate

Nebuliser solution equivalent to 2.5 mg salbutamol in 2.5 mL single dose units, 30

Pressurised inhalation equivalent to 100 micrograms salbutamol per dose, 200 doses (CFC-free formulation)

Nebuliser solution equivalent to 5 mg salbutamol in 2.5 mL single dose units, 30

Salmeterol Xinafoate

Pressurised inhalation equivalent to 25 micrograms salmeterol per dose, 120 doses

Powder for oral inhalation in breath actuated device equivalent to 50 micrograms salmeterol per dose, 60 doses

Silver Sulfadiazine with Chlorhexidine Gluconate

Cream 10 mg-2 mg per g, 50 g

Cream 10 mg-2 mg per g, 100 g

Sirolimus

Oral solution 1 mg per mL, 60 mL

Sodium Cromoglycate

Pressurised inhalation 1 mg per dose, 200 doses

Pressurised inhalation 1 mg per dose, 200 doses (CFC-free formulation)

Pressurised inhalation 5 mg per dose, 112 doses (CFC-free formulation)

Eye drops 20 mg per mL, 10 mL

Sterculia with Frangula Bark

Granules 620 mg-80 mg per g, 500 g

Sulfacetamide Sodium

Eye drops 100 mg per mL, 15 mL

Terbutaline Sulfate

Powder for oral inhalation in breath actuated device 500 micrograms per dose, 200 doses

Testosterone

Transdermal gel 50 mg in 5 g sachet, 30

Transdermal patches 12.2 mg, 60

Transdermal patches 24.3 mg, 30

Theophylline

Oral solution 133.3 mg per 25 mL, 500 mL

Timolol Maleate

Eye gel equivalent to 1 mg timolol per g, 5 g

Eye drops equivalent to 2.5 mg timolol per mL, 5 mL

Eye drops equivalent to 5 mg timolol per mL, 5 mL

Eye drops (gellan gum solution) equivalent to 2.5 mg timolol per mL, 2.5 mL

Eye drops (gellan gum solution) equivalent to 5 mg timolol per mL, 2.5 mL

Tobramycin

Eye drops 3 mg per mL, 5 mL

Eye ointment 3 mg per g, 3.5 g

Tramadol Hydrochloride

Oral drops 100 mg per mL, 10 mL

Travoprost

Eye drops 40 micrograms per mL, 2.5 mL

Travoprost with Timolol Maleate

Eye drops 40 micrograms travoprost with timolol maleate equivalent to 5 mg timolol per mL, 2.5 mL

Triamcinolone Acetonide with Neomycin Sulfate, Gramicidin and Nystatin

Ear drops 1 mg-2.5 mg (neomycin)-250 micrograms-100,000 units per g, 7.5 mL

Ear ointment 1 mg-2.5 mg (neomycin)-250 micrograms-100,000 units per g, 5 g

Trimethoprim with Sulfamethoxazole

Paediatric oral suspension 40 mg-200 mg per 5 mL, 100 mL

\n```\n\nCreams Salicylic Acid and Sulfur Aqueous APF\n\nDusting Powders Zinc, Starch and Talc APF 15\n\nZinc, Starch and Talc BPC 1973\n\nEar Drops Aluminium Acetate APF\n\nAluminium Acetate BP\n\nSodium Bicarbonate APF\n\nSodium Bicarbonate BP\n\nSpirit APF\n\nEye Drops containing Cocaine Hydrochloride BP —\n\nEye Drops, Other —\n\nEye Lotions —\n\nInhalations Benzoin and Menthol APF\n\nMenthol APF\n\nMenthol and Eucalyptus BP 1980\n\nLinctuses containing Codeine Phosphate BP Codeine APF\n\nLinctuses, Other —\n\nLotions Aluminium Acetate Aqueous APF\n\nMixtures containing Codeine Phosphate BP —\n\nMixtures, Other Gentian Alkaline APF\n\nKaolin BPC 1968\n\nKaolin and Opium APF 14\n\nMagnesium Trisilicate BPC 1968\n\nMagnesium Trisilicate and Belladonna BPC 1968\n\nMixtures for Children containing Codeine Phosphate BP —\n\nMixtures for Children, Other —\n\nMouth Washes Thymol Compound APF 15\n\nNasal Instillations —\n\nOintments Benzoic Acid Compound APF\n\nBenzoic Acid Compound (extemporaneous formula) BP\n\nBoric Acid, Olive Oil and Zinc Oxide QHF\n\nSalicylic Acid APF\n\nSalicylic Acid (extemporaneous formula) BP\n\nPaints Podophyllin Compound APF 16\n\nPodophyllin Compound BP\n\nSalicylic Acid APF\n\nPastes containing Cocaine Hydrochloride BP —\n\nPastes, Other Zinc APF\n\nZinc Compound (extemporaneous formula) BP\n\nPowders for Internal Use Magnesium Trisilicate BP\n\nSolutions —\n\n| |\n| --- |\n\n> Notes to the Determination under paragraph 98C (1) (b) (No. PB 50 of 2006)\n\n> Note 1\n\n> Note: The Determination under paragraph 98C (1) (b) (No. PB 50 of 2006) (in force under paragraph 98C (1) (b) of the National Health Act 1953) as shown in this compilation is amended as indicated in the Tables below.\n\n> Note: > Note: Table of Instruments\n\n| Title | Date of FRLI Registration | Date ofcommencement | Application, saving ortransitional provisions |\n| ----------------- | ----------------------------- | ------------------- | --------------------------------------------- |\n| No. PB 50 of 2006 | 14 Nov 2006 (see F2006L03689) | 1 Dec 2006 | |\n| No. PB 9 of 2007 | 11 Jan 2007 (see F2007L00080) | 1 Feb 2007 | — |\n\n> Note: > Note: Table of Amendments\n\n```html\n

ad. = added or inserted am. = amended rep. = repealed rs. = repealed and substituted

Provision affected

How affected

Schedule 4

Schedule 4............

am. No. PB 9 of 2007

\n```","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-realtime","completionTokens":1910},"content_quality":"ok","complexity_score":6,"rejection_reason":"","scope_assessment":{"changed":false,"description":"The determination remains focused on its original purpose: specifying pharmaceutical benefits categories and pricing mechanisms under paragraph 98C(1)(b) of the National Health Act 1953. It does not expand beyond the technical administrative matters concerning PBS supply rules and dangerous drug classifications."},"complexity_factors":["7 defined terms cross-referencing the National Health Act 1953 and Regulations","4 detailed schedules listing specific drug formulations, strengths, and pack sizes","Conditional pricing logic based on brand selection, state location, and prescription type","Interaction with separate determinations made under subsection 98B(1) of the Act","Technical pharmaceutical terminology throughout (extemporaneous preparations, admixtures, etc.)"],"plain_english_summary":"This rulebook sets how the government pays pharmacies under Australia’s Pharmaceutical Benefits Scheme, by categorising medicines and fixing supply and pricing rules. It defines medicines mixed on the spot (Schedule 1), rapidly perishable/sterile ingredients like Water for Injections (Schedule 2), certain strong “dangerous drugs” that attract an extra handling fee (Schedule 3), and items that must be dispensed in full packs (Schedule 4). If a brand is prescribed the government pays for it; otherwise it pays for the cheapest brand in the state capital. It affects pharmacists, prescribers and patients."},"flash_summary":{"complexity_score":5,"scope_assessment":{"changed":true,"description":"The Determination expressly repeals Determination No. PB 32 of 2006 (s2) and, per the compilation notes, was subsequently amended by No. PB 9 of 2007 (affecting Schedule 4). Mechanically, its core statutory purpose (setting PBS‑related product lists and payment/supply rules) remains, but the specific scope was changed by replacing the earlier Determination and by later amendment to the schedules and pack‑supply rules, thereby updating which items and formulations are covered and how they are supplied and paid for."},"complexity_factors":["Extensive cross‑references to the National Health Act 1953 and the National Health (Pharmaceutical Benefits) Regulations 1960 (definitions and payment rules).","Large, detailed Schedules listing many drugs, formulations and pack sizes (technical pharmaceutical detail).","Different rules depending on whether a prescription names a brand or not (pricing calculation nuance: s5–6).","Special rules for extemporaneously‑prepared vs ready‑prepared benefits, and a carve‑out for standard formula preparations (definitions and deeming: ss3,8).","Pack‑supply rule forcing complete packs for certain items when lesser quantities are prescribed (s7), with operational impacts on pharmacists and inventory.","Administrative election process to opt into an alternate payment calculation with a minimum 3‑month binding period and revocation mechanics (s9).","Repeal and amendment history built into the instrument (s2 and Notes), requiring readers to track prior instruments and later amendments (No. PB 32 of 2006; No. PB 9 of 2007).","Technical language (e.g. 'approved price to pharmacists', 'Commonwealth price', 'extemporaneously‑prepared') that links statutory terms to operational outcomes."],"plain_english_summary":"This Determination replaces an earlier instrument and sets which pharmaceutical products (including extemporaneous and ready‑prepared items) are subsidised, how pack sizes must be supplied, and how reimbursement is calculated (using approved pharmacist prices or the lowest Commonwealth price). It lists unstable or single‑use ingredients and drugs attracting special fees, and requires written elections to Medicare Australia for certain extemporaneous supplies. Who pays: the Commonwealth under the National Health Act. Who decides: Medicare Australia (CEO) for election administration."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-act-1953-determination-under-paragraph-98c-1-b-no-pb-50-of-2006","history":"/api/acts/national-health-act-1953-determination-under-paragraph-98c-1-b-no-pb-50-of-2006/history","analysis":"/api/acts/national-health-act-1953-determination-under-paragraph-98c-1-b-no-pb-50-of-2006/analysis","conflicts":"/api/acts/national-health-act-1953-determination-under-paragraph-98c-1-b-no-pb-50-of-2006/conflicts","importantCases":"/api/acts/national-health-act-1953-determination-under-paragraph-98c-1-b-no-pb-50-of-2006/important-cases","documents":"/api/acts/national-health-act-1953-determination-under-paragraph-98c-1-b-no-pb-50-of-2006/documents"}}